StrandOmics Description
A robust platform for automatic variant prioritization and clinical interpretation, as well as report generation, is essential to ensure efficient reporting of NGS-based clinical trials. Strand Omics, a cloud-based platform that is HIPAA-compliant and fast, drives our clinical diagnostics practice. It has been refined over 4 years with over 10,000 clinical reports and multiple peer reviewed publications. Strand Omics is a combination of bioinformatics algorithms and curated databases, visualization interfaces, and reporting capabilities. It offers specialized workflows that can be used for rare inherited disorders and somatic tumor profiling tests. The platform has over 10,000 variants curated to oncogenicity, 100 genes that are curated for druggability across multiple types of cancer, and 500 drugs that have been curated for evidence.
Integrations
Company Details
Media
- How engineering teams use real-time customer data to achieve business goals.
- How to elevate your business to a new level of engineering efficiency with AI.
- Strategies used by engineering teams at Instacart, Staples Canada, Televisa Univision, CrossFit, and ClearScore to improve KPIs and drive efficiencies.